This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (148)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

J. David Curb, MD; Nemat O. Borhani, MD; Thomas P. Blaszkowski, PhD; Neal Zimbaldi; Socrates Fotiu, MD; Wallace Williams, PhD

JAMA. 1985;253(22):3263-3268.

Abstract
The large number of participants (5,485 patients) in the Hypertension Detection and Follow-Up Program, Stepped Care, form the largest group to date on which detailed surveillance of long-term antihypertensive therapy and drug side effects has been reported. Over a five-year period, among all hypertensive persons (mild, moderate, and severe combined) who were not taking antihypertensive medications at the beginning of the study and who attended the clinic at least once during the five-year trial, a total of 9.3% had definite or probable side effects severe enough to cause discontinuation of the drug treatment in question. An additional 23.4% had drug treatment discontinued due to possible side effects. Within the mild, moderate, and severe hypertension categories, 8.6%, 11%, and 12%, respectively, had definite or probable side effects. The incidence of side effects declined over the five years in all race-sex groups. Five-year incidence of total side effects was 29.8% in those aged 60 to 69 years at entry and 38.0%, 36.8%, and 34.1%, respectively, in those aged 50 to 59, 40 to 49, and 30 to 39 years. Sexually related side effects required discontinuation of treatment in 8.3% of male participants. However, less than 1% of active participants required hospitalization for side effects. No death that could be attributed to side effects was detected. Thus, the Hypertension Detection and Follow-up Program data, which have previously demonstrated the beneficial effects of antihypertensive therapy, confirm the relative safety of such therapy.

(JAMA 1985;253:3263-3268)

Author Affiliations
From the University of Hawaii Schools of Public Health and Medicine, Honolulu (Dr Curb); the School of Medicine, University of California at Davis (Dr Borhani); the National Heart, Lung, and Blood Institute, Bethesda, Md (Drs Blaszkowski and Williams); the Hypertension Detection and Follow-up Program Coordinating Center, Houston (Mr Zimbaldi); and the Georgetown Hypertension Clinic, Washington, DC (Dr Fotiu).

Footnotes
Reprint requests to Scientific Project Officer, Hypertension Detection and Follow-up Program, DHVD, National Heart, Lung, and Blood Institute, National Institutes of Health, Room 6A-08, Federal Bldg, 7550 Wisconsin Ave, Bethesda, MD 20205.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis
Cooper and Murphy
Circulation 2007;115:263-270.
FULL TEXT  

Erectile Dysfunction and Cardiovascular Disease
Russell et al.
Mayo Clin Proc. 2004;79:782-794.
ABSTRACT  

Self-rated health among cardiovascular drug users in a study of Swedish twins
Svardh et al.
Scand J Public Health 1998;26:223-231.
ABSTRACT  

Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS)
Grimm et al.
Hypertension 1997;29:8-14.
ABSTRACT | FULL TEXT  

Discontinuation of Antihyperlipidemic Drugs -- Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?
Andrade et al.
NEJM 1995;332:1125-1131.
ABSTRACT | FULL TEXT  

Impact of the Treatment of Isolated Systolic Hypertension on Behavioral Variables: Results From the Systolic Hypertension in the Elderly Program
Applegate et al.
Arch Intern Med 1994;154:2154-2160.
ABSTRACT  

Sexual Dysfunction With Antihypertensive Drugs
Prisant et al.
Arch Intern Med 1994;154:730-736.
ABSTRACT  

Reflections on the Impact of Antihypertensive Medications on Mood, Sedation, and Neuropsychologic Functioning
Dimsdale
Arch Intern Med 1992;152:35-39.
ABSTRACT  

The Impact of Diuretic Therapy on Reported Sexual Function
Chang et al.
Arch Intern Med 1991;151:2402-2408.
ABSTRACT  

The Ambiguous Relation between Aging and Adverse Drug Reactions
Gurwitz and Avorn
ANN INTERN MED 1991;114:956-966.
ABSTRACT  

Effect of Antihypertensives on Sexual Function and Quality of Life: The TAIM Study
Wassertheil-Smoller et al.
ANN INTERN MED 1991;114:613-620.
ABSTRACT  

The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension
Cummings et al.
Arch Intern Med 1991;151:250-259.
ABSTRACT  

Combination of Converting Enzyme Inhibitor With Diuretic for the Treatment of Hypertension
Townsend and Holland
Arch Intern Med 1990;150:1175-1183.
ABSTRACT  

Hypertension in Elderly Patients
Applegate
ANN INTERN MED 1989;110:901-915.
ABSTRACT  

Maximally Reducing Cardiovascular Risk in the Treatment of Hypertension
Kaplan
ANN INTERN MED 1988;109:36-40.
ABSTRACT  

Efficacy and Safety of Guanadrel in Elderly Hypertensive Patients
Owens and Dunn
Arch Intern Med 1988;148:1515-1518.
ABSTRACT  

The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
1988 Joint National Committee et al.
Arch Intern Med 1988;148:1023-1038.
ABSTRACT  

Are the Days of the Sphygmomanometer Past?
Tifft
Arch Intern Med 1988;148:518-519.
ABSTRACT  

Adverse Reactions to Antihypertensive Drugs
Flegel et al.
JAMA 1987;257:1329-1330.
ABSTRACT  

Relaxation Therapy for Hypertension: Comparison of Effects With Concomitant Placebo, Diuretic, and {beta}-Blocker
Jacob et al.
Arch Intern Med 1986;146:2335-2340.
ABSTRACT  

Statement on Hypertension in the Elderly
The Working Group on Hypertension in the Elderly
JAMA 1986;256:70-74.
ABSTRACT  

Sexual Dysfunction and Ocular Timolol
Katz
JAMA 1986;255:37-38.
ABSTRACT